Anthrax vaccine (BioSante/DynPort)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnthrax vaccine (BioSante/DynPort)
Drug Alias Name炭疽疫苗（BioSante/DynPort）
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDynport Vaccine Company LlcBiosante
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosanteDynport Vaccine Company Llc
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A